Looking Ahead: Tardive Dyskinesia Care

Slideshow

Recent studies and reviews report great progress in bringing TD under control.

Related Videos
Related Content

A Look Back at the 2022 Annual Psychiatric Times® World CME Conference

October 3rd 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

The Week in Review: September 25-29

September 30th 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

NDA Submitted for Investigational Muscarinic Antipsychotic in the Treatment of Schizophrenia

September 28th 2023

Cannabis and Schizophrenia: Implications in the Legalization Era

September 25th 2023

A Look Back at the 2022 Annual Psychiatric Times® World CME Conference

October 3rd 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

The Week in Review: September 25-29

September 30th 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

NDA Submitted for Investigational Muscarinic Antipsychotic in the Treatment of Schizophrenia

September 28th 2023

Cannabis and Schizophrenia: Implications in the Legalization Era

September 25th 2023

A Look Back at the 2022 Annual Psychiatric Times® World CME Conference

October 3rd 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

The Week in Review: September 25-29

September 30th 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

NDA Submitted for Investigational Muscarinic Antipsychotic in the Treatment of Schizophrenia

September 28th 2023

Cannabis and Schizophrenia: Implications in the Legalization Era

September 25th 2023
© 2023 MJH Life Sciences

All rights reserved.